Active Pharmaceutical Ingredient API News and Research

RSS

Dicom Systems' latest API improves the Teleradiology network experience for healthcare professionals

Dicom Systems, consolidating their reputation for continued and groundbreaking innovation, are preparing to launch the latest addition to their DCMSYS family: API for Advanced Statistical reports and graphs, and for monitoring.

19 Nov 2009

Movea unveils SmartMotion Development Kit at MEDICA 2009

Movea, the global leader in technology, patents, and products for motion-sensing applications, today unveiled its SmartMotion™ Development Kit (SMDK) at MEDICA 2009. The SMDK allows application developers, OEMs, and healthcare researchers to effortlessly add motion-sensing capabilities to their products or R&D projects.

18 Nov 2009

Genta announces financial results for the third quarter of 2009, reduces workforce to cut payroll costs

Genta Incorporated today announced financial results for the quarter and nine months ended September 30, 2009. The Company also announced a restructuring, reduction in workforce, and re-ordering of clinical development priorities.

16 Nov 2009

AMRI reports $47.7 million total revenue for the third quarter of 2009

AMRI today reported financial and operating results for the third quarter ended September 30, 2009.

9 Nov 2009

Althea Technologies offers formulation development services

Althea Technologies, Inc., a leading provider of development and manufacturing services for biopharmaceutical products announced the addition of customized Formulation Development to the company's platform of services, which will be overseen by the newly appointed Dr. James Matsuura, Director of Formulation Development.

5 Nov 2009

NFC-based services open up new global dimension in payment and ticketing areas

NFC is a recent technology offering short-range wireless connectivity which enables smart mobile consumer devices to interact quickly and easily when brought close together or touching. Set up is fast and systems can be intuitively easy to use.

4 Nov 2009

Teva Pharmaceutical Industries net sales up 25%

Teva Pharmaceutical Industries Ltd. today reported results for the quarter ended September 30, 2009.

3 Nov 2009

Perrigo to sell its Israel Consumer Products business to Emilia Group

Perrigo Company today announced that it has signed a definitive agreement to sell its Israel Consumer Products business along with the related production assets in Israel to Emilia Group, a subsidiary of O. Feller Holdings Ltd., for 205 million New Israeli Shekels (approximately $54 million).

2 Nov 2009

BioCryst Pharmaceuticals reports fiscal 2009 third-quarter results

BioCryst Pharmaceuticals, Inc. announced financial results for the quarter and nine months ended September 30, 2009 and provided a corporate update regarding clinical programs and potential emergency use of intravenous (i.v.) peramivir.

29 Oct 2009

Evonik Industries to acquire Tippecanoe Laboratories from Eli Lilly

Eli Lilly and Company today announced the sale of its Tippecanoe Laboratories manufacturing facility to Evonik Industries AG, one of the world's largest chemical companies.

15 Oct 2009

IQPC to hold the 8th Annual Polymorphism & Crystallization Scientific Forum

Organized by IQPC, the 8th Annual Polymorphism & Crystallization Scientific Forum will be held October 26-28, 2009 at the Hub Cira Center in Philadelphia, PA (www.polymorphismforum.com).

From IQPC Ltd 15 Oct 2009

SAFC Pharma expands contract manufacturing services

SAFC Pharma®, a business segment of SAFC®, a member of the Sigma-Aldrich® Group, today announced the completion of an addition to its Carlsbad, Calif., facility that expands the Company's contract manufacturing services for its late phase and commercial clients.

13 Oct 2009

Phyton Biotech purchases NPI’s assets

Phyton Biotech, LLC (Phyton), an affiliate of Phyton, Inc., today announced that it has purchased the assets of Natural Pharmaceuticals, Inc. (NPI), a leading manufacturer of oncology drug active pharmaceutical ingredients (API’s).

13 Oct 2009

DNA Guide's personal genome management software demonstrated at the Health 2.0 conference

DNA Guide presented a live demo of its unique personal genome management software on the main stage of the Health 2.0 conference in San Francisco on October 7th. DNA Guide’s software is based on an issued US patent (US Patent: 7089498) whereby the values in a persons DNA are used for security and then Geographic Information Systems technology is utilized to place massive genetic datasets in a visual format - effectively opening up DNA navigation to a whole new audience.

12 Oct 2009

Arch Pharmalabs collaborates with Orochem Technologies to manufacture an API in India

Arch Pharmalabs, Ltd., a leading provider of small molecule process R&D and full life-cycle custom synthesis and manufacturing services, announced today it has entered into a strategic partnership with Orochem Technologies, Inc., to manufacture a U.S. innovator’s active pharmaceutical ingredient (API) in late-stage clinical development using Simulated Moving Bed (SMB) technology.

12 Oct 2009

Xcelience's Xcelodose 120S precision powder micro-dosing system accelerates drug development

Xcelience, a leader in early development services, recognizes that providing access to a third, dedicated Xcelodose® 120S precision powder micro-dosing system in the experimental area enables clients to accelerate drug development with preliminary compound evaluation, earlier go/ no-go decisions and flexible options for experimental studies.

8 Oct 2009

Labopharm's trazodone API supplier Angelini resolves manufacturing facility deficiencies

Labopharm Inc. today announced that it has been informed by Angelini, the manufacturer of the active pharmaceutical ingredient (API) for the Company's novel trazodone formulation, that it has received a letter from the U.S. Food and Drug Administration (FDA) stating that Angelini has appropriately addressed all deficiencies cited by the FDA following its inspection of the manufacturing facility in June and July of this year.

8 Oct 2009

LiveData awarded a SBIR grant for integrating medical technologies

LiveData, Inc., a leader in real-time data integration and display, has been awarded a Phase II Small Business Innovation Research grant from the U.S. Army Telemedicine and Advanced Technology Research Center (TATRC). LiveData will use the $730,000 grant to develop an integrated clinical environment with CIMIT’s Medical Device Plug-and-Play (MD PnP) team.

7 Oct 2009

Nutra Pharma to launch prescription analgesic for severe chronic pain treatment

Nutra Pharma Corp. (OTCBB: NPHC), a biotechnology company that is developing treatments for Adrenomyeloneuropathy (AMN), HIV and Multiple Sclerosis (MS), has announced today its intent to launch a prescription analgesic, Nyloxin Rx, for the treatment of severe (Stage 3) chronic pain.

7 Oct 2009

Salix Pharmaceuticals granted rights to use Lupin's bioadhesive drug delivery technology

Pharma Major, Lupin Ltd today announced that it has granted Salix Pharmaceuticals, Ltd. the exclusive rights for the United States to its bioadhesive drug delivery technology for use with Rifaximin.

6 Oct 2009